Development of novel drug particles.
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- HT942524D0011
- Awardee
-
Crititech Particle Engineering Solutions, LLC UEI QMLLX81RZ6V9
- Awarding agency
-
Defense Health Agency
Department of Defense
- Task orders
- 3 $318,184 obligated
Award facts
- Opportunity
-
- HT942524R0116 Solicitation number
- Combined order value
- $318,184 Current and potential, with all options
- Last date to order 42% complete
- IDV ceiling 45% used
- $709,995.75
- Maximum order
- $709,995.75
- Award type
- Single award
- Contracting staff
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- AJ11 General Science And Technology R&D Services; General Science And Technology; Basic Research
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Defense Health Agency awarded a single-award indefinite-delivery contract to Crititech Particle Engineering Solutions, LLC on September 9, 2024, with a ceiling value of $709,995.75 for development of novel drug particles for inhalational therapy. The contract carries no set-aside designation and extends through September 8, 2029.
All work is performed at Crititech's facility in Lawrence, Kansas. The IDIQ governs the development of novel drug particles to support the Defense Health Agency's medical and healthcare innovation objectives.
Three delivery orders have been issued under this IDC. The first, valued at $109,995.75 and awarded September 9, 2024, had an ultimate completion date of September 8, 2025. The second, valued at $67,592.51 and awarded July 1, 2025, targeted completion on October 30, 2025. The third, valued at $140,595.49 and awarded December 3, 2025, is scheduled for completion December 2, 2026. All delivery orders are firm fixed-price and carry no set-aside designations. Crititech retains performance responsibilities with no major subcontractors identified in the awards.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Development of novel drug particles for inhalational therapy | Defense Health Agency | $140,595 | |
| Development of novel drug particles | Defense Health Agency | $67,593 | |
| Development of novel drug particles | Defense Health Agency | $109,996 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract HT942524D0011?
HT942524D0011 was awarded to Crititech Particle Engineering Solutions, LLC by Defense Health Agency (Department of Defense) on September 9, 2024.
How much is contract HT942524D0011 worth?
Orders under HT942524D0011 have obligated $318,184. HT942524D0011's own ceiling is $709,996. A single order can be worth up to $709,996.
How many orders have been placed under contract HT942524D0011?
3 orders have been placed under HT942524D0011, the latest on December 3, 2025.
Who can order from contract HT942524D0011?
HT942524D0011 is a single award indefinite delivery contract.
Was contract HT942524D0011 competed?
The extent of competition for HT942524D0011 was not competed. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV